Hanmi Pharm Co Ltd (128940) — Capital Reinvestment Ratio
Hanmi Pharm Co Ltd (128940) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩42.02 Billion) in capital expenditures (₩15.95 Billion). See debt-free asset ratio of Hanmi Pharm Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hanmi Pharm Co Ltd Capital Reinvestment Ratio (2010–2024)
This chart tracks Hanmi Pharm Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check 128940 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hanmi Pharm Co Ltd (2010–2024)
Year-by-year Capital Reinvestment Ratio for Hanmi Pharm Co Ltd from 2010 to 2024. For live market cap and broader valuation context, see 128940 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | ₩193.49 Billion | ₩62.55 Billion | ▲ +60.1% |
| 2023 | 0.20x | ₩216.54 Billion | ₩43.74 Billion | ▲ +7.9% |
| 2022 | 0.19x | ₩162.27 Billion | ₩30.38 Billion | ▲ +89.5% |
| 2021 | 0.10x | ₩201.92 Billion | ₩19.95 Billion | ▼ -64.2% |
| 2020 | 0.28x | ₩151.53 Billion | ₩41.82 Billion | ▼ -97.9% |
| 2019 | 13.35x | ₩12.45 Billion | ₩166.13 Billion | ▲ +90.3% |
| 2018 | 7.02x | ₩25.98 Billion | ₩182.27 Billion | ▲ +1192.8% |
| 2016 | 0.54x | ₩412.97 Billion | ₩224.09 Billion | ▼ -54.4% |
| 2015 | 1.19x | ₩101.71 Billion | ₩121.07 Billion | ▲ +285.2% |
| 2013 | 0.31x | ₩85.99 Billion | ₩26.57 Billion | ▲ +40.9% |
| 2012 | 0.22x | ₩63.27 Billion | ₩13.87 Billion | ▼ -31.3% |
| 2011 | 0.32x | ₩61.30 Billion | ₩19.56 Billion | ▼ -70.5% |
| 2010 | 1.08x | ₩18.94 Billion | ₩20.46 Billion | — |